Biogen and Stoke Therapeutics Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 American Epilepsy Society (AES) Annual Meeting Biogen Nawigacja wpisu Three healthcare innovations that could transform medicine – Fast Company ’Married to Medicine’s Dr. Contessa Metcalfe Confirms Dr. Heavenly Kimes Is Still Her No. 1 Opp – Entertainment Tonight
